EcoDrugPlus

Tyrosine Hydroxylase

Ensembl ID : ENSAOCG00000006689
Gene Symbol: TH
3 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSAOCG00000000216
Gene Symbol: TYK2
3 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSAOCG00000003025
Gene Symbol: TIE1
3 Cross references
207 Possible Orthologues:

Tyrosine-Protein Kinase Jak2-Like

Ensembl ID : ENSAOCG00000006970
Gene Symbol: LOC111573731
3 Cross references
198 Possible Orthologues:

Tyrosine-Protein Kinase Jak2-Like

Ensembl ID : ENSAOCG00000022397
Gene Symbol: LOC111571538
3 Cross references
194 Possible Orthologues:

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSAOCG00000005036
Gene Symbol: LOC111580728
3 Cross references
196 Possible Orthologues:

Tyrosine-Protein Kinase Fyna

Ensembl ID : ENSAOCG00000001387
Gene Symbol: LOC111573260
3 Cross references
192 Possible Orthologues:

Tyrosine-Protein Kinase Yes

Ensembl ID : ENSAOCG00000009840
Gene Symbol: LOC111565072
3 Cross references
197 Possible Orthologues:

Uncharacterized Loc111573826

Ensembl ID : ENSAOCG00000001718
Gene Symbol: LOC111573826
2 Cross references
194 Possible Orthologues:

Uncharacterized Loc111582470

Ensembl ID : ENSAOCG00000008864
Gene Symbol: LOC111582470
2 Cross references
192 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSAOCG00000011235
Gene Symbol: UTS2R
4 Cross references
92 Possible Orthologues:

Utrophin

Ensembl ID : ENSAOCG00000022254
Gene Symbol: UTRN
4 Cross references
253 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).